Print Page  Close Window

Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2017 Annual Report on Form 10-K - PDF 2017 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$17.28
Change (%) Stock is Up 0.14 (0.82%)
Volume1,043,280
Data as of 06/22/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/30/18OraSure Technologies to Present at Jefferies Global Healthcare Conference
BETHLEHEM, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at Jefferies Global Healthcare Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on June 6, 2018, at approximately 11:00 AM Eastern Time (8:00 AM Pacific Time).  Interested inv... 
Printer Friendly Version
05/14/18OraSure Technologies to Present at the UBS Global Healthcare Conference   
BETHLEHEM, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on May 22, 2018, at approximately 3:30 PM Eastern Time (12:30 PM Pacific Time).  Interested in... 
Printer Friendly Version
05/04/18OraSure Technologies Appoints New Chief Financial Officer
BETHLEHEM, Pa., May 04, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roberto Cuca has been appointed as the Company’s new Chief Financial Officer, effective as of June 8, 2018.  Mr. Cuca will initially serve as Senior Advisor to the Company until his appointment is effective.  Mr. Cuca will succeed Ronald H. Spair, who will retire from the Company on the same date. Since Se... 
Printer Friendly Version
05/02/18OraSure Announces 2018 First Quarter Financial Results
BETHLEHEM, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the quarter ended March 31, 2018. Financial Highlights Consolidated net revenues for the first quarter of 2018 were $42.0 million, a 29% increase from the first quarter of 2017. Consolidated net product revenues were $38.3 million, representing a 22% increase over the... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources